No abstract

No abstract

Dengue fever is a severe, widespread, and neglected disease with more than 2 million diagnosed infections per year. The dengue virus NS2B/NS3 protease (PR) represents a prime target for rational drug design. At the moment, there are no clinical PR inhibitors (PIs) available. We have identified diaryl (thio)ethers as candidates for a novel class of PIs. Here, we report the selective and noncompetitive inhibition of the serotype 2 and 3 dengue virus PR in vitro and in cells by benzothiazole derivatives exhibiting 50% inhibitory concentrations (IC 50 s) in the low-micromolar range. Inhibition of replication of DENV serotypes 1 to 3 was specific, since all substances influenced neither hepatitis C virus (HCV) nor HIV-1 replication. Molecular docking suggests binding at a specific allosteric binding site. In addition to the in vitro assays, a cell-based PR assay was developed to test these substances in a replication-independent way. The new compounds inhibited the DENV PR with IC 50 s in the low-micromolar or submicromolar range in cells. Furthermore, these novel PIs inhibit viral replication at submicromolar concentrations. Dengue viruses (DENVs) are enveloped positive-strand RNA viruses and belong to the family Flaviviridae. DENV is the most important arthropod-borne viral infection. Over one-third of the world population lives in areas of DENV endemicity, and an estimated 390 million infections occur every year. In addition, the number of countries having experienced DENV epidemics has risen from 9 in 1970 to more than 100 today (1, 2). Furthermore, the number of diagnosed infections across America, Southeast Asia, and the Western Pacific nearly doubled from 1.2 million in 2008 to over 2.3 million in 2010 (2). Four different DENV serotypes have been identified so far. Recently, evidence for an additional subtype has been presented (3). Serotypes 1 to 4 are now prevalent in Asia, Africa, and America, and the regions where dengue is endemic are still increasing (4-6), with dengue endangering even Europe and the United States due to vector spread. DENV infections can be associated with dengue fever, but up to 88% of the infections remain inapparent (7). These nonpersistent infected patients serve besides persistently infected mosquitoes as a virus reservoir. Severe DENV infections and especially reinfections may lead to dengue hemorrhagic fever and dengue shock syndrome, with lethality up to 5% (2,8,9). There is neither a vaccination nor a specific treatment for DENV infections.The DENV genome contains a single open reading frame, which encodes the structural proteins capsid, membrane precursor (prM), and envelope and the nonstructural proteins NS1, NS2, NS3, NS4, and NS5 (10). Cellular proteases and the viral serine protease (PR) are responsible for cleaving the viral precursor polyprotein into functional proteins. The DENV PR consists of the amino-terminal domain of the NS3 protein and requires NS2B, a 14-kDa protein, as a cofactor to form a stable complex. This heterodimeric PR cleaves at the capsid-prM, NS2A/NS2...

A series of nine 1,3-dipoles, belonging to the families of diazonium betaines, nitrilium betaines, and azomethine betaines, has been studied by means of the breathing-orbital valence bond ab initio method. Each 1,3-dipole is described as a linear combination of three valence bond structures, two zwitterions and one diradical, for which the weights in the total wave function can be quantitatively estimated. In agreement with an early proposition of Harcourt, the diradical character of 1,3-dipoles is shown to be a critical feature to favor 1,3-dipolar cycloaddition. Within each family, a linear relationship is evidenced between the weight of the diradical structure in the 1,3-dipole and the barrier to cycloaddition to ethylene or acetylene, with correlation coefficients of 0.98-1.00. The barrier heights also correlate very well with the transition energies from ground state to pure diradical states of the 1,3-dipoles at equilibrium geometry. Moreover, the weight of the diradical structure is shown to increase significantly in all 1,3-dipoles from their equilibrium geometries to their distorted geometries in the transition states. A mechanism for 1,3-dipolar cycloaddition is proposed, in which the 1,3-dipole first distorts so as to reach a reactive state that possesses some critical diradical character and then adds to the dipolarophile with little or no barrier. This mechanism is in line with the recently proposed distortion/interaction energy model of Ess and Houk and their finding that the barrier heights for the cycloaddition of a given 1,3-dipole to ethylene and acetylene are nearly the same, despite the exothermicity difference (Ess, D. H. and Houk, K. N. J. Am. Chem. Soc. 2008, 130, 10187).